Becton, Dickinson and Company
BDXAction· NYSE· USD
L'essentiel à retenir
- • Dernier cours : 165,62 $US (cours différé)
- • Variation sur 1 an : +19,45 %
- • Type d'actif : Action
- • Place de cotation : NYSE
- • Devise de cotation : USD
- • Clôture précédente : 165,45 $US
Informations
- Symbole
- BDX
- Type
- Action
- Place
- NYSE
- Devise
- USD
- Clôture veille
- 165,45 $US
- Variation 1 an
- +19,45 %
BD (BDX) Stock May Be 19% Undervalued On Fresh MedTech AI Adoption News
Becton Dickinson stock has delivered a 20.9% one year return, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples look closer to fair. The 20.9% return over the past year suggests investors have already priced in some optimism, which raises the bar for any further upside to be supported by fundamentals. Growing use of data and AI tools across medical device companies, highlighted by...
Yahoo Finance · 30/07/2026 · lire l'article ↗
Becton Dickinson (BDX) On Its Brazil Semaglutide Push And The Valuation Narrative
Becton Dickinson (BDX) is back in focus after announcing a collaboration with EMS to support the launch of a semaglutide therapy in Brazil. The deal spotlights BD’s Vystra injection pen platform in chronic disease care. See our latest analysis for Becton Dickinson. Becton Dickinson’s recent EMS partnership and dividend affirmation come as the stock trades at US$166.34, with a 90-day share price return of 14.47% but a year-to-date share price decline of 14.67%. The 1-year total shareholder...
Yahoo Finance · 29/07/2026 · lire l'article ↗
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and EMS, one of Brazil's leading pharmaceutical companies, today announced their collaboration in the launch of a semaglutide therapy in Brazil. This collaboration and launch underscore a shared commitment to addressing patients' ongoing healthcare challenges associated with chronic diseases, including obesity and type 2 diabetes.
Yahoo Finance · 29/07/2026 · lire l'article ↗
BD Board Declares Dividend
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on September 30, 2026, to holders of record on September 9, 2026. The indicated annual dividend rate is $4.20 per share.
Yahoo Finance · 28/07/2026 · lire l'article ↗
AcuityMD Now Trusted By More Than 500 Medical Device Companies, Including 16 of Top 20
BOSTON, July 22, 2026--AcuityMD, the AI platform for MedTech, today announced it is now trusted by more than 500 medical device (MedTech) companies, including 16 of the top 20, such as Becton Dickinson, Olympus, and Teleflex. The milestone reflects a growing shift across the medical device industry, as commercial teams adopt AI to better understand where care is happening and to uncover new opportunities. Across its customer base, AcuityMD has helped commercial teams generate billions in pipelin
Yahoo Finance · 22/07/2026 · lire l'article ↗
Mike Garrison to Retire from BD
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has informed the company of his intent to retire after more than 20 years with BD, effective Oct. 2.
Yahoo Finance · 22/07/2026 · lire l'article ↗
Titres et résumés fournis par les sources d'origine (flux Yahoo Finance). Cliquez pour lire l'article complet.
Questions fréquentes sur Becton, Dickinson and Company
- Quel est le cours actuel de Becton, Dickinson and Company ?
- Le dernier cours connu de Becton, Dickinson and Company (BDX) est de 165,62 $US (cours différé, fourni à titre informatif). Cette page est mise à jour régulièrement.
- Quelle est la performance de Becton, Dickinson and Company sur un an ?
- Sur les 12 derniers mois, Becton, Dickinson and Company (BDX) affiche une variation de +19,45 %. Les performances passées ne préjugent pas des performances futures.
- Comment suivre Becton, Dickinson and Company dans mon portefeuille ?
- Créez un compte gratuit sur AssetApp, ajoutez BDX à l'un de vos portefeuilles et suivez sa valeur, vos plus-values et son actualité — aux côtés de vos autres actifs.
Actifs similaires
Becton, Dickinson and Company : suivre cet actif
Becton, Dickinson and Company (BDX) est une action coté sur NYSE en USD. Avec AssetApp, ajoutez BDX à votre portefeuille pour suivre sa valeur, vos gains latents et réalisés, et l'évolution de votre patrimoine — sans dépendre de votre courtier.
Suivre BDX gratuitement